• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Out-of-pocket Spending on Orphan Drug Prescriptions Among Commercially Insured Adults in 2014.

作者信息

Chua Kao-Ping, Conti Rena M

机构信息

Department of Pediatrics and Communicable Diseases, Child Health Evaluation and Research Center, University of Michigan Medical School, Ann Arbor, MI, USA.

Department of Markets, Public Policy, and Law, Boston University Questrom School of Business, Boston, MA, USA.

出版信息

J Gen Intern Med. 2019 Mar;34(3):338-340. doi: 10.1007/s11606-018-4694-1.

DOI:10.1007/s11606-018-4694-1
PMID:30324293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6420515/
Abstract
摘要

相似文献

1
Out-of-pocket Spending on Orphan Drug Prescriptions Among Commercially Insured Adults in 2014.2014年商业保险成年人中孤儿药处方的自付费用
J Gen Intern Med. 2019 Mar;34(3):338-340. doi: 10.1007/s11606-018-4694-1.
2
Buprenorphine Use and Spending for Opioid Use Disorder Treatment: Trends From 2003 to 2015.美沙酮使用与阿片类药物使用障碍治疗费用：2003 年至 2015 年趋势
Psychiatr Serv. 2018 Jul 1;69(7):832-835. doi: 10.1176/appi.ps.201700315. Epub 2018 May 8.
3
US health spending accelerated in 1998.1998年美国医疗支出加速增长。
BMJ. 2000 Jan 22;320(7229):203.
4
Out-of-pocket payments in arthritis: spur to prudent purchasing or red herring?关节炎的自付费用：是促使谨慎购买的因素还是误导因素？
Arthritis Rheum. 2008 Aug;58(8):2225-7. doi: 10.1002/art.23724.
5
Growth in spending on substance use disorder treatment services for the privately insured population.为有私人保险的人群提供物质使用障碍治疗服务的支出增长。
Drug Alcohol Depend. 2016 Mar 1;160:143-50. doi: 10.1016/j.drugalcdep.2015.12.024. Epub 2015 Dec 31.
6
US Health Care Spending by Payer and Health Condition, 1996-2016.美国按支付方和健康状况划分的医疗保健支出，1996-2016 年。
JAMA. 2020 Mar 3;323(9):863-884. doi: 10.1001/jama.2020.0734.
7
Out-of-Pocket Spending for Insulin, Diabetes-Related Supplies, and Other Health Care Services Among Privately Insured US Patients With Type 1 Diabetes.美国 1 型糖尿病私人保险患者的胰岛素、糖尿病相关用品和其他医疗保健服务的自付费用。
JAMA Intern Med. 2020 Jul 1;180(7):1012-1014. doi: 10.1001/jamainternmed.2020.1308.
8
Out-of-Pocket Spending for Hospitalizations Among Nonelderly Adults.非老年成年人住院的自付费用。
JAMA Intern Med. 2016 Sep 1;176(9):1325-32. doi: 10.1001/jamainternmed.2016.3663.
9
Trends In Orphan Drug Spending And Out-Of-Pocket Spending Among US Children, 2013-18.2013 - 2018年美国儿童孤儿药支出及自付费用趋势
Health Aff (Millwood). 2020 Oct;39(10):1806-1811. doi: 10.1377/hlthaff.2020.00595.
10
Health spending projections for 2002-2012.2002年至2012年的医疗支出预测。
Health Aff (Millwood). 2003 Jan-Jun;Suppl Web Exclusives:W3-54-65. doi: 10.1377/hlthaff.w3.54.

引用本文的文献

1
Disentangling the Cost of Orphan Drugs Marketed in the United States.厘清美国上市的罕见病药物成本
Healthcare (Basel). 2023 Feb 13;11(4):558. doi: 10.3390/healthcare11040558.
2
Spending For Orphan Indications Among Top-Selling Orphan Drugs Approved To Treat Common Diseases.用于治疗常见疾病的畅销孤儿药的孤儿适应症支出。
Health Aff (Millwood). 2021 Mar;40(3):453-460. doi: 10.1377/hlthaff.2020.01442.
3
Orphan Drugs Offer Larger Health Gains but Less Favorable Cost-effectiveness than Non-orphan Drugs.罕见病药物比非罕见病药物能带来更大的健康收益，但成本效益却更低。
J Gen Intern Med. 2020 Sep;35(9):2629-2636. doi: 10.1007/s11606-020-05805-2. Epub 2020 Apr 13.
4
Pediatric Orphan Drug Indications: 2010-2018.儿科罕用药适应证：2010-2018 年。
Pediatrics. 2020 Apr;145(4). doi: 10.1542/peds.2019-3128. Epub 2020 Mar 3.
5
The impact of the Orphan Drug Act on Food and Drug Administration-approved therapies for rare skin diseases and skin-related cancers.《孤儿药法案》对美国食品药品监督管理局批准的罕见皮肤病和皮肤相关癌症治疗方法的影响。
J Am Acad Dermatol. 2019 Sep;81(3):867-877. doi: 10.1016/j.jaad.2019.05.025. Epub 2019 May 16.

本文引用的文献

1
Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia.慢性髓性白血病患者酪氨酸激酶抑制剂的费用分担与依从性。
J Clin Oncol. 2014 Feb 1;32(4):306-11. doi: 10.1200/JCO.2013.52.9123. Epub 2013 Dec 23.